into ASSET.
Statistical Consideration
The trial was designed to detect a reduction in overall fatality at 6 months from an estimated 15% down to 12% (3% absolute, 20% relative reduction). A trial in 5,000 patients would have a greater than 90% power to detect such a difference and would be sufficient also to examine mortality at 1 month.
Ethics
The study was conducted in accordance with the Declaration of Helsinki, and the protocol was approved by the Ethical Committees of all participating centers.
Definitions
The following definitions were used: 
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